FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
The use of chemotherapeutics for the treatment of keloid scars
3808PDF: 1794HTML: 547 -
The efficacy of cryotherapy compared to other modalities in the management of palmoplantar warts: a systematic review and network meta-analysis
1254PDF: 647SUPPLEMENTARY MATERIAL: 187HTML: 31 -
Metastatic basal cell carcinoma to the bone: a case of bone metastasis in uncommon sites
1021PDF: 487Supplementary Table: 214HTML: 10 -
Pityriasis following COVID-19 vaccinations: a systematic review
1297PDF: 722Supplementary Material: 127HTML: 76 -
13 | Spatial contexture of tertiary lymphoid structures as a predictor of recurrence in early-stage melanoma Chiara Bungaro1, Sabino Strippoli1, Daniele Carenza1, Ivana De Risi1, Rossella Villani1, Teresa Squicciarini1, Anna Albano1, Ileana De Roma1, Fabio Mele 2, Margherita Sonnessa2, Concetta Saponaro2, Francesco Alfredo Zito2, Arianna Bozzi3, Benedetta Apollonio1, Raffaella Massafra3, Michele Guida1 | 1Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori "Giovanni Paolo II"; 2Pathology Unit, IRCCS Istituto Tumori "Giovanni Paolo II"; 3Biostatistics and Bioinformatics Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
316 -
21 | Melanoma in situ: long-term outcomes and follow-up strategies based on risk stratification Beatrice De Checchi1, Paolo del Fiore2, Irene Russo2, Chiara Trevisiol2, Marco Domenico Mazza2, Saveria Tropea2, Francesco Russano2, Mauro Alaibac3, Carlomaria Gianesini4, Giovanni Madeo4, Simone Mocellin2|4 | 1Department of Medicine, University of Padua, Padua; 2Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; 3Department of Dermatology, University of Padua; 4Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
289 -
Giant acquired acral fibrokeratoma: A case report
939PDF: 568HTML: 148 -
-
Treatment modalities of necrobiosis lipoidica: a concise systematic review
2860PDF: 1877Suppl. Table: 430HTML: 491 -
Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols
764PDF: 284SUPPLEMENTARY MATERIAL: 68HTML: 1

